Global Veterinary Pharmacovigilance Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Veterinary Pharmacovigilance market size was valued at USD 722.4 million in 2022 and is forecast to a readjusted size of USD 1690.1 million by 2029 with a CAGR of 12.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry is driven by the need to ensure that animal health products are safe for consumption by animals and that they do not pose any risks to human health. Competition in the market is expected to remain intense as companies strive to gain a competitive advantage by offering innovative solutions and offering competitive prices.
One of the key trends includes the adoption of new technologies such as electronic reporting systems and data analytics tools. These technologies allow for more efficient and accurate reporting as well as monitoring of adverse events, and can help to identify potential safety issues before they become more serious.
Pharmacovigilance (PV) is a science relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem, came into existence to monitor the adverse drug reactions (ADRs) throughout the life period of a drug.
Veterinary pharmacovigilance concerns monitoring, evaluating and improving the safety of veterinary medicines, with particular reference to adverse events in animals and human beings related to the use of these medicines. It also involves collection of information on adverse events due to off-label use and investigations of the validity of the withdrawal period and of potential environmental problems.
The medicines which are used for the treatment of animals shall be observed for their short- and long-term effects on animals and the effect on the environment because they may affect the ecosystem in one or other way.
This report is a detailed and comprehensive analysis for global Veterinary Pharmacovigilance market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Veterinary Pharmacovigilance market size and forecasts, in consumption value ($ Million), 2018-2029
Global Veterinary Pharmacovigilance market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Veterinary Pharmacovigilance market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Veterinary Pharmacovigilance market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Veterinary Pharmacovigilance
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Veterinary Pharmacovigilance market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Accenture, ArisGlobal, Azierta Contract Science Support Consulting, Biologit and Ennov, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Veterinary Pharmacovigilance market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
In-house
Contract Outsourcing
Market segment by Application
Companion Animals
Farm Animals
Market segment by players, this report covers
Accenture
ArisGlobal
Azierta Contract Science Support Consulting
Biologit
Ennov
Indivirtus
Knoell
Oy Medfiles Ltd.
Pharsafer Associates Limited
Sarjen Systems Pvt. Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Veterinary Pharmacovigilance product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Veterinary Pharmacovigilance, with revenue, gross margin and global market share of Veterinary Pharmacovigilance from 2018 to 2023.
Chapter 3, the Veterinary Pharmacovigilance competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Veterinary Pharmacovigilance market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Veterinary Pharmacovigilance.
Chapter 13, to describe Veterinary Pharmacovigilance research findings and conclusion.